BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Wang QQ, Hussain L, Yu PH, Yang C, Zhu CY, Ma YF, Wang SC, Yang T, Kang YY, Yu WJ, Maimaitiyiming Y, Naranmandura H. Hyperthermia promotes degradation of the acute promyelocytic leukemia driver oncoprotein ZBTB16/RARα. Acta Pharmacol Sin 2022. [PMID: 36216898 DOI: 10.1038/s41401-022-01001-6] [Reference Citation Analysis]
2 Shao YM, Sharavyn B, Huang P, Naranmandura H, Wang QQ. Development of Metal-Based Drugs and Application in Clinical Treatment. NPJ 2022;12. [DOI: 10.2174/2210315511666210512025010] [Reference Citation Analysis]
3 Noguera NI, Catalano G, Banella C, Divona M, Faraoni I, Ottone T, Arcese W, Voso MT. Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies. Cancers (Basel) 2019;11:E1591. [PMID: 31635329 DOI: 10.3390/cancers11101591] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
4 Hussain L, Maimaitiyiming Y, Islam K, Naranmandura H. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance. Seminars in Oncology 2019;46:133-44. [DOI: 10.1053/j.seminoncol.2019.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]